2026-01-15 - Analysis Report
**English Report**

**Company Overview**
Northrop Grumman Corp is an aerospace and defense technology company.

**Return Rate Comparison**
|  | Rate | Rate_vs | Rate_Difference |
| --- | --- | --- | --- |
| Cumulative Return of Review Stock | 56.79% | 92.89% | 36.10% |

Divergence: The review stock is diverging from the comparison stock (S&P 500, VOO) by 36.10%.

**Alpha, Beta Analysis**
| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | -6.0% | 23.7% | -10.0% | 0.7 | 35.1B |
| 2017-2019 | 15.0% | 23.7% | -2.0% | 0.7 | 49.2B |
| 2018-2020 | -25.0% | 23.7% | -46.0% | 0.8 | 43.6B |
| 2019-2021 | 40.0% | 12.9% | -3.0% | 0.7 | 55.4B |
| 2020-2022 | 18.0% | 16.9% | 19.0% | 0.6 | 78.1B |
| 2021-2023 | 23.0% | 16.9% | 22.0% | 0.3 | 67.0B |
| 2022-2024 | -14.0% | 16.9% | -33.0% | 0.3 | 67.2B |
| 2023-2025 | -1.0% | 17.7% | -63.0% | 0.1 | 81.6B |

**Recent Stock Price Fluctuations**
| Metric | Value |
| --- | --- |
| Close | $653.14 |
| Last-market | {'change': 4.42} |
| 5-day SMA | $623.51 |
| 20-day SMA | $590.50 |
| 60-day SMA | $577.35 |

**RSI, PPO Index Indicators**
| Metric | Value |
| --- | --- |
| RSI | 70.95 |
| PPO | 1.09 |
| MRI (Market Risk Indicator) | 0.70 (Medium Investment) |
| Hybrid Signal | Buy |
| Risk Level | Medium (MRI 0.70) |
| Expected Return (%) | -46.30% |

**Recent News & Significant Events**
News headlines and links are considered in the analysis.

**Analyst Opinions**
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.09 (~Buy)
- Opinions: 21
- Target Price (avg/high/low): 669.58 / 770.00 / 533.00

**Recent Earnings Analysis**
| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-10-21 | 7.69 | $10.42 B |
| 2025-07-22 | 8.17 | $10.35 B |
| 2025-04-22 | 3.33 | $9.47 B |
| 2024-10-24 | 7.02 | $10.00 B |
| 2025-10-21 | 7.02 | $10.00 B |

**Financial Information**

**Revenue and Profitability**
| Quarter | Revenue | Profit Margin |
| --- | --- | --- |
| 2025-09-30 | $10.42B | 21.37% |
| 2025-06-30 | $10.35B | 21.35% |
| 2025-03-31 | $9.47B | 16.69% |
| 2024-12-31 | $10.69B | 18.08% |
| 2024-09-30 | $10.00B | 21.07% |

**Capital and Profitability**
| Quarter | Equity | ROE |
| --- | --- | --- |
| 2025-09-30 | $15.99B | 6.88% |
| 2025-06-30 | $15.47B | 7.59% |
| 2025-03-31 | $14.98B | 3.21% |
| 2024-12-31 | $15.29B | 8.27% |
| 2024-09-30 | $14.75B | 6.96% |

**Comprehensive Analysis (Summary of previous items)**

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.